Literature DB >> 16283236

Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta.

A Otsuka1, K Azuma, T Iesaki, F Sato, T Hirose, T Shimizu, Y Tanaka, H Daida, R Kawamori, H Watada.   

Abstract

AIMS/HYPOTHESIS: Several epidemiological data suggest that patients with postprandial hyperglycaemia are at high risk of cardiovascular disease. The aim of this study was to elucidate the effect of a glucose 'spike' on monocyte adhesion to rat aortic endothelial cells.
MATERIALS AND METHODS: Monocyte adhesion to endothelial cells in vivo was quantitated using an en face method for observation of endothelial surface after immunohistochemical staining for CD68 in the thoracic aortas of Sprague-Dawley rats after several kinds of blood glucose rises.
RESULTS: The number of monocytes adhering to endothelial cells increased at 30 min after injection of glucose in 8-week-old Sprague-Dawley rats. The increased adhesion returned to the basal level at 120 min after glucose injection, concomitantly with the return of blood glucose levels to normal. The infusion of octreotide to inhibit endogenous insulin secretion did not prevent the glucose-induced increase in monocyte adhesion to endothelial cells. On the other hand, the number of monocytes adhering to endothelial cells did not increase in rats with streptozotocin-induced diabetes and sustained hyperglycaemia. CONCLUSIONS/
INTERPRETATION: Our data demonstrate that a temporary rise in blood glucose levels can in itself promote a reversible increase in monocyte adhesion to arterial endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283236     DOI: 10.1007/s00125-005-0005-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.

Authors:  M Morigi; S Angioletti; B Imberti; R Donadelli; G Micheletti; M Figliuzzi; A Remuzzi; C Zoja; G Remuzzi
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

2.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

3.  Local 24-h hyperglycemia does not affect endothelium-dependent or -independent vasoreactivity in humans.

Authors:  A J Houben; N C Schaper; C H de Haan; F C Huvers; D W Slaaf; P W de Leeuw; C Nieuwenhuijzen Kruseman
Journal:  Am J Physiol       Date:  1996-06

4.  Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus.

Authors:  H Shige; T Ishikawa; M Suzukawa; T Ito; K Nakajima; K Higashi; M Ayaori; S Tabata; F Ohsuzu; H Nakamura
Journal:  Am J Cardiol       Date:  1999-11-15       Impact factor: 2.778

5.  Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

Authors:  H Kawano; T Motoyama; O Hirashima; N Hirai; Y Miyao; T Sakamoto; K Kugiyama; H Ogawa; H Yasue
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

6.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

7.  Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia.

Authors:  C M Akbari; R Saouaf; D F Barnhill; P A Newman; F W LoGerfo; A Veves
Journal:  J Vasc Surg       Date:  1998-10       Impact factor: 4.268

8.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

10.  Evidence that glucose increases monocyte binding to human aortic endothelial cells.

Authors:  J A Kim; J A Berliner; R D Natarajan; J L Nadler
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

View more
  33 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

2.  Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta.

Authors:  W L Jin; K Azuma; T Mita; H Goto; A Kanazawa; T Shimizu; F Ikeda; Y Fujitani; T Hirose; R Kawamori; H Watada
Journal:  Diabetologia       Date:  2011-04-16       Impact factor: 10.122

3.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

Review 4.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

5.  The impact of intraday glucose variability on coronary artery spasm in patients with dysglycemia.

Authors:  Tsuyoshi Ito; Taku Ichihashi; Hiroshi Fujita; Tomonori Sugiura; Junki Yamamoto; Shuichi Kitada; Kosuke Nakasuka; Yu Kawada; Nobuyuki Ohte
Journal:  Heart Vessels       Date:  2019-02-02       Impact factor: 2.037

6.  Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.

Authors:  Casey M Rebholz; Morgan E Grams; Yuan Chen; Alden L Gross; Yingying Sang; Josef Coresh; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2017-10-15       Impact factor: 4.897

Review 7.  Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.

Authors:  Ebenezer A Nyenwe; Terri W Jerkins; Guillermo E Umpierrez; Abbas E Kitabchi
Journal:  Metabolism       Date:  2011-01       Impact factor: 8.694

Review 8.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

Review 9.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.

Authors:  Theodore Mazzone; Alan Chait; Jorge Plutzky
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.